Merck expects bumpy ride due to generics - CBS News

Frazier noted the company's Januvia family of diabetes pills has become No. 1 worldwide among branded diabetes medicines. It's been buoyed by the approvals last year of Juvisync, the first combo pill for people with diabetes and cholesterol ...

Study: Docs barring pharma reps has unexpected side effects - FiercePharma

It cut back on adoption of a brand-new, first-in-class diabetes drug--Merck's ($MRK) Januvia--which could be good for healthcare costs, but potentially kept patients from a therapy that might work better for them, the study authors concluded.

Novo’s Insulin Pill Quest is Holy Grail for Diabetics - Bloomberg

New hires include Nazaneen Pourkavoos, who helped develop an extended-release version of Janumet, a pill that combines the Januvia diabetes treatment with an older drug known as metformin, for Merck & Co. (MRK) Pourkavoos, whose role is to find ...

Merck: Manufacturing Portfolio Health With Dividend Income - Seekingalpha.com

Revenue climbed 1.3 percent to $11.7 billion, boosted by sales of the Januvia and Janumet diabetes drugs. Net income for Merck & Co Inc. rose to $1.74 billion (56 cents per share) vs. $1.04 billion (34 cents per share) in the same quarter a year earlier.

Royalty Pharma Raises $600 Million of Debt - msnbc.com

Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, announced that it has successfully issued $600 million of incremental Term Loan B debt through RPI Finance Trust ("RPIFT"), bringing ...

Merck: Will Singulair Expiration Sink Its Stock? - Seekingalpha.com

Januvia and Janumet are both used to improve control of blood sugar in patients with type II diabetes, which is currently at epidemic stage in the U.S. and is increasing rapidly throughout the developed economies. Isentress is used in combination therapy ...

Merck CEO: Generics, economy to make 2012-13 tough - Yahoo Finance

Frazier noted the company's Januvia family of diabetes pills has become No. 1 worldwide among branded diabetes medicines. It's been buoyed by the approvals last year of Juvisync, the first combo pill for people with diabetes and cholesterol ...

Canada Drugs Online Provides Cost-Cutting Strategies and Lower Prices on Branded Diabetes Drugs - YAHOO!

They may buy Januvia or generic Glucophage for significantly lower prices than they could find in the United States. Canada Drugs Online is proudly verified by PharmacyChecker.com and is a Certified Canadian International Pharmacy (CIPA).

What Could Move the Markets Today - msnbc.com

Bolstering Merck's revenue were its diabetes drugs, Januvia and Janumet, which grew their sales more than 20% and now account for more than 10% of Merck's revenue. And like Pfizer, Merck looks to its drug pipeline, which includes odanacatib ...

Diabetes Therapeutics Market to 2017 - pressreleasepoint.com

Market Research  GBI Research estimates that the market share of Eli Lilly and Merck in the diabetes market will increase due to the potential success of Teplizumab, which is in Phase III, and Januvia, which was launched in 2006. In addition, Novo Nordisk ...